HSBC Holdings’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.05K | Sell |
12,306
-3,822
| -24% | -$1.57K | ﹤0.01% | 2523 |
|
|
2025
Q1 | $9.66K | Sell |
16,128
-26
| -0.2% | -$16 | ﹤0.01% | 2529 |
|
|
2024
Q4 | $25.6K | Buy |
16,154
+2,235
| +16% | +$3.54K | ﹤0.01% | 2600 |
|
|
2024
Q3 | $25.7K | Buy |
13,919
+3,139
| +29% | +$5.79K | ﹤0.01% | 2537 |
|
|
2024
Q2 | $62.6K | Buy |
+10,780
| New | +$62.6K | ﹤0.01% | 2426 |
|
|
2024
Q1 | – | Sell |
-17,793
| Closed | -$263K | – | 2609 |
|
|
2023
Q4 | $263K | Sell |
17,793
-17,611
| -50% | -$260K | ﹤0.01% | 1890 |
|
|
2023
Q3 | $168K | Buy |
+35,404
| New | +$168K | ﹤0.01% | 1962 |
|